Form 4: Omnicell Executive Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Omnicell's EVP & Chief Legal/Admin Officer, Corey J. Manley, sold 3,880 shares of common stock for $33.25 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Corey J. Manley, Executive Vice President and Chief Legal/Administrative Officer of Omnicell, Inc. (OMCL), reported a sale of common stock.
- The transaction involved the disposition of 3,880 shares of Omnicell Common Stock.
- The shares were sold at a price of $33.25 per share.
- The sale occurred on September 12, 2025.
- This transaction was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Manley on June 13, 2025.
- Following this reported transaction, Mr. Manley beneficially owns 110,653 shares of Omnicell Common Stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-arranged Rule 10b5-1 trading plan indicates it was scheduled for personal financial planning rather than being based on new, material non-public information. The transaction size is also relatively small in the context of the company's overall market capitalization.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived as a lack of confidence, though the pre-planned nature mitigates this concern.
Future Outlook
No forward-looking statements or guidance were provided in this insider transaction report.
Industry Context
This filing reports a routine insider transaction and does not contain information directly related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, but the pre-planned nature of the sale under a 10b5-1 plan typically minimizes concerns about management's confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/13/2025 | Date the Rule 10b5-1 trading plan was adopted by Corey J. Manley. |
| 09/12/2025 | Date of the reported transaction (sale of common stock). |
| 09/16/2025 | Date the Form 4 statement was signed and filed. |
Recommendation
holdThis Form 4 reports a routine insider sale by an executive under a pre-established 10b5-1 trading plan. Such transactions are typically for personal financial management and do not usually signal a change in the company's fundamental outlook or warrant a shift in investment recommendation. The relatively small size of the transaction further supports a 'hold' recommendation, as it does not provide new material information to alter an existing investment thesis.
Keywords
Omnicell, OMCL, Insider Trading, Form 4, Corey J. Manley, Stock Sale, 10b5-1 Plan, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.